Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation

Published:2022-10 Issue: Volume:121 Page:106951
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Fujiwara Shin-ichiro,Murahashi Rui,Nakashima Hirotomo,Matsuoka Sae,Ikeda Takashi,Toda Yumiko,Ito Shoko,Kawaguchi Shin-ichiro,Nagayama Takashi,Umino Kento,Minakata Daisuke,Morita Kaoru,Nakano Hirofumi,Ashizawa Masahiro,Yamamoto Chihiro,Hatano Kaoru,Sato Kazuya,Ohmine Ken,Kanda Yoshinobu

Funder

Astellas Pharma

Pfizer

Takeda Pharmaceutical Company

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. What is the best daunorubicin dose and schedule for acute myeloid leukemia induction?;Pophali;Curr. Treat. Options Oncol.,2017

2. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur. J. Heart Fail.,2017

3. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group;Armenian;Lancet Oncol.,2015

4. Cardiotoxicity of anthracyclines;Cardinale;Front. Cardiovasc. Med.,2020

5. Equivalence ratio for daunorubicin to doxorubicin in relation to late heart failure in survivors of childhood cancer;Feijen;J. Clin. Oncol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC;2024-07-26

2. Sex Differences in the Development of Anthracycline-Associated Heart Failure;Journal of Cardiac Failure;2023-11

3. Identification and protection of early cardiotoxicity in acute myeloid leukemia patients undergoing transplantation;Hematology;2023-07-25

4. Daunorubicin;Reactions Weekly;2023-07-01